KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Common Equity (2017 - 2025)

Historic Common Equity for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $6.7 billion.

  • Elanco Animal Health's Common Equity rose 346.47% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 346.47%. This contributed to the annual value of $6.1 billion for FY2024, which is 204.08% down from last year.
  • As of Q3 2025, Elanco Animal Health's Common Equity stood at $6.7 billion, which was up 346.47% from $6.8 billion recorded in Q2 2025.
  • Elanco Animal Health's Common Equity's 5-year high stood at $8.0 billion during Q1 2021, with a 5-year trough of $5.9 billion in Q2 2024.
  • In the last 5 years, Elanco Animal Health's Common Equity had a median value of $6.8 billion in 2025 and averaged $6.9 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Common Equity surged by 2020.72% in 2021, and later tumbled by 1991.91% in 2024.
  • Elanco Animal Health's Common Equity (Quarter) stood at $7.5 billion in 2021, then dropped by 2.92% to $7.3 billion in 2022, then dropped by 14.62% to $6.2 billion in 2023, then dropped by 2.04% to $6.1 billion in 2024, then grew by 10.71% to $6.7 billion in 2025.
  • Its Common Equity was $6.7 billion in Q3 2025, compared to $6.8 billion in Q2 2025 and $6.4 billion in Q1 2025.